Literature DB >> 32394571

Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum.

Roman Kotov1, Katherine G Jonas1, William T Carpenter2, Michael N Dretsch3, Nicholas R Eaton4, Miriam K Forbes5, Kelsie T Forbush6, Kelsey Hobbs7, Ulrich Reininghaus8,9,10, Tim Slade11, Susan C South12, Matthew Sunderland11, Monika A Waszczuk1, Thomas A Widiger13, Aidan G C Wright14, David H Zald15, Robert F Krueger7, David Watson16.   

Abstract

The Hierarchical Taxonomy of Psychopathology (HiTOP) is a scientific effort to address shortcomings of traditional mental disorder diagnoses, which suffer from arbitrary boundaries between psychopathology and normality, frequent disorder co-occurrence, heterogeneity within disorders, and diagnostic instability. This paper synthesizes evidence on the validity and utility of the thought disorder and detachment spectra of HiTOP. These spectra are composed of symptoms and maladaptive traits currently subsumed within schizophrenia, other psychotic disorders, and schizotypal, paranoid and schizoid personality disorders. Thought disorder ranges from normal reality testing, to maladaptive trait psychoticism, to hallucinations and delusions. Detachment ranges from introversion, to maladaptive detachment, to blunted affect and avolition. Extensive evidence supports the validity of thought disorder and detachment spectra, as each spectrum reflects common genetics, environmental risk factors, childhood antecedents, cognitive abnormalities, neural alterations, biomarkers, and treatment response. Some of these characteristics are specific to one spectrum and others are shared, suggesting the existence of an overarching psychosis superspectrum. Further research is needed to extend this model, such as clarifying whether mania and dissociation belong to thought disorder, and explicating processes that drive development of the spectra and their subdimensions. Compared to traditional diagnoses, the thought disorder and detachment spectra demonstrated substantially improved utility: greater reliability, larger explanatory and predictive power, and higher acceptability to clinicians. Validated measures are available to implement the system in practice. The more informative, reliable and valid characterization of psychosis-related psychopathology offered by HiTOP can make diagnosis more useful for research and clinical care.
© 2020 World Psychiatric Association.

Entities:  

Keywords:  HiTOP; clinical utility; detachment; in­troversion; personality disorders; psychosis; psychotic disorders; psychoticism; schizophrenia; thought disorder

Year:  2020        PMID: 32394571      PMCID: PMC7214958          DOI: 10.1002/wps.20730

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  341 in total

Review 1.  All for One and One for All: Mental Disorders in One Dimension.

Authors:  Avshalom Caspi; Terrie E Moffitt
Journal:  Am J Psychiatry       Date:  2018-04-06       Impact factor: 18.112

2.  Childhood maltreatment and the structure of common psychiatric disorders.

Authors:  Katherine M Keyes; Nicholas R Eaton; Robert F Krueger; Katie A McLaughlin; Melanie M Wall; Bridget F Grant; Deborah S Hasin
Journal:  Br J Psychiatry       Date:  2011-12-08       Impact factor: 9.319

3.  Testing DSM-5 in routine clinical practice settings: feasibility and clinical utility.

Authors:  Eve K Mościcki; Diana E Clarke; S Janet Kuramoto; Helena C Kraemer; William E Narrow; David J Kupfer; Darrel A Regier
Journal:  Psychiatr Serv       Date:  2013-10       Impact factor: 3.084

Review 4.  Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies.

Authors:  Luca De Peri; Alessandra Crescini; Giacomo Deste; Paolo Fusar-Poli; Emilio Sacchetti; Antonio Vita
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  DSM-5 personality traits and DSM-IV personality disorders.

Authors:  Christopher J Hopwood; Katherine M Thomas; Kristian E Markon; Aidan G C Wright; Robert F Krueger
Journal:  J Abnorm Psychol       Date:  2012-01-16

6.  Modeling psychopathology structure: a symptom-level analysis of Axis I and II disorders.

Authors:  K E Markon
Journal:  Psychol Med       Date:  2009-06-11       Impact factor: 7.723

Review 7.  Schizotypal personality disorder: a current review.

Authors:  Daniel R Rosell; Shira E Futterman; Antonia McMaster; Larry J Siever
Journal:  Curr Psychiatry Rep       Date:  2014-07       Impact factor: 5.285

Review 8.  Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies.

Authors:  Filippo Varese; Feikje Smeets; Marjan Drukker; Ritsaert Lieverse; Tineke Lataster; Wolfgang Viechtbauer; John Read; Jim van Os; Richard P Bentall
Journal:  Schizophr Bull       Date:  2012-03-29       Impact factor: 9.306

9.  Two gene co-expression modules differentiate psychotics and controls.

Authors:  C Chen; L Cheng; K Grennan; F Pibiri; C Zhang; J A Badner; E S Gershon; C Liu
Journal:  Mol Psychiatry       Date:  2012-11-13       Impact factor: 15.992

10.  Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder.

Authors:  Zhongming Zhao; Jiabao Xu; Jingchun Chen; Sanghyeon Kim; Mark Reimers; Silviu-Alin Bacanu; Hui Yu; Chunyu Liu; Jingchun Sun; Quan Wang; Peilin Jia; Fengping Xu; Yong Zhang; Kenneth S Kendler; Zhiyu Peng; Xiangning Chen
Journal:  Mol Psychiatry       Date:  2014-08-12       Impact factor: 15.992

View more
  38 in total

1.  Folk Classification and Factor Rotations: Whales, Sharks, and the Problems With the Hierarchical Taxonomy of Psychopathology (HiTOP).

Authors:  Gerald J Haeffel; Bertus F Jeronimus; Bonnie N Kaiser; Lesley Jo Weaver; Peter D Soyster; Aaron J Fisher; Ivan Vargas; Jason T Goodson; Wei Lu
Journal:  Clin Psychol Sci       Date:  2021-05-18

2.  Internet-based field trials of the ICD-11 chapter on mental disorders.

Authors:  Michele Fabrazzo
Journal:  World Psychiatry       Date:  2022-02       Impact factor: 49.548

3.  Klerman's "credo" reconsidered: neo-Kraepelinianism, Spitzer's views, and what we can learn from the past.

Authors:  Jerome C Wakefield
Journal:  World Psychiatry       Date:  2022-02       Impact factor: 49.548

4.  Childhood maltreatment is associated with cortical thinning in people with eating disorders.

Authors:  Giammarco Cascino; Antonietta Canna; Andrea Gerardo Russo; Francesco Monaco; Fabrizio Esposito; Francesco Di Salle; Palmiero Monteleone; Alessio Maria Monteleone
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-19       Impact factor: 5.760

5.  Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration.

Authors:  Dan J Stein; Steven J Shoptaw; Daniel V Vigo; Crick Lund; Pim Cuijpers; Jason Bantjes; Norman Sartorius; Mario Maj
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

6.  Incremental integration of nosological innovations is improving psychiatric diagnosis and treatment.

Authors:  Robert F Krueger
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

7.  Hierarchical Symptom Components in Early Psychosis.

Authors:  Julia M Longenecker; Gretchen L Haas; Dean F Salisbury
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

8.  A Hierarchical Taxonomy of Psychopathology (HiTOP) Primer for Mental Health Researchers.

Authors:  Christopher C Conway; Miriam K Forbes; Susan C South
Journal:  Clin Psychol Sci       Date:  2021-06-23

Review 9.  A dimensional perspective on the genetics of obsessive-compulsive disorder.

Authors:  Nora I Strom; Takahiro Soda; Carol A Mathews; Lea K Davis
Journal:  Transl Psychiatry       Date:  2021-07-21       Impact factor: 6.222

Review 10.  Narrative identity in the psychosis spectrum: A systematic review and developmental model.

Authors:  Henry R Cowan; Vijay A Mittal; Dan P McAdams
Journal:  Clin Psychol Rev       Date:  2021-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.